Congenital hypothyroidism medical therapy
Congenital hypothyroidism Microchapters |
Differentiating Congenital hypothyroidism from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Congenital hypothyroidism medical therapy On the Web |
American Roentgen Ray Society Images of Congenital hypothyroidism medical therapy |
Risk calculators and risk factors for Congenital hypothyroidism medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
The goal of newborn screening programs is to detect and start treatment within the first 1-2 weeks of life. Treatment consists of a daily dose of thyroxine, available as a small tablet. The generic name is levothyroxine, and several brands are available. Commonly used brands in North America are Synthroid, Levoxyl, Unithroid, and Levothroid. The tablet is crushed and given to the infant with a small amount of water or milk. The most commonly recommended dose range is 10-15 μg/kg daily, typically 37.5 or 44 μg.[1]
Within a few weeks, the T4 and TSH levels are rechecked to confirm that they are being normalized by treatment. As the child grows up, these levels are checked regularly to maintain the right dose. The dose increases as the child grows.
References
- ↑ Journal of Pediatric Endocinology and Metabolism 20:559 PMID 17642417